Form D · Biotechnology
Frontier Bio Corp
Hayward, CA · CIK 0002107814
Offering snapshot reported Nov 10, 2026 · SEC filing
- Reported sold
- $380K Offering amount: $1M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 27, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 10, 2026 | Initial | $380,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-604247
Simple Agreement for Future Equity (SAFE), convertible into preferred stock
Source: Form D, filed Nov 10, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric Bennett | Director, Executive |
| Terrence Mc Kenna | Director |
| Matthew Shore | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3515 Breakwater Ave
Hayward, CA, 94545
Hayward, CA, 94545